Atlas Arteria · ASX:ALX
Atlas Arteria — Macquarie Australia Conference 2019
12 slides from Atlas Arteria's conference presentation, May 2, 2019

Slide 1: ASX Release: Investor Presentation – Macquarie Australia Conference
02 May 2019 For personal use only ASX RELEASE Atlas Arteria INVESTOR PRESENTATION – MACQUARIE AUSTRALIA CONFERENCE A copy of the investor presentation to be delivered at the Macquarie Australia Conference later today is attached. ______________________________________________________________________

Slide 2: Macquarie Australia Conference Presentation 2019
For personal use only Atlas Arteria Macquarie Australia Conference Presentation 2019 2 May 2019

Slide 3: Important notice and disclaimer
Important notice and disclaimer For personal use only Disclaimer Atlas Arteria (ALX) comprises Atlas Arteria Limited (ACN 141 075 201) (ATLAX) and Atlas Arteria International Limited (Registration No. 43828) (ATLIX). This presentation has been prepared by ALX based on information available to them.

Slide 4: Vision
Vision For personal use only Vision… To enhance the economic and environmental efficiency of communities through the ownership and operation of safe and efficient transport solutions And by doing so to… Deliver growing distributions and enhance the value of our businesses for the benefit of our shar

Slide 5: Delivery of Internalisation
Atlas Arteria Delivery of Internalisation For personal use only Securityholder approval for Internalisation Approved 15 May 2018 Macquarie performance fees Final payment made for 30 June 18 Internalisation of management to be achieved by 15 May 2019 Achieved on 1 April 2019 Macquarie base management

Slide 6: Strategic Framework
Strategic Framework For personal use only Successfully complete the transition to internal management Manage the business and build value • Streamline the current structures where possible • Disciplined capital management to build sustainable distributions • Active operational management • Lengthen

Slide 7: The Atlas Arteria Business
The Atlas Arteria Business For personal use only 2018 Proportionate EBITDA Contribution Atlas Arteria Business Portfolio ADELAC Warnow 2% 1% Dulles 12% APRR ADELAC 25% 25% Concession expiry: 2035 Concession expiry: 2060 Dulles Greenway Warnow 100%1 100% Concession expiry: 2056 Concession expiry: 205

Slide 8: APRR Financial performance
APRR Financial performance APRR’s Revenue and EBITDA growth underpinned by positive traffic performance and toll increases For personal use only 5 year financial performance (€m) – 100% 2018 financial performance 73.2% 73.8% Revenue performance was driven by traffic growth, toll 71.8% 72.4% 75% 3,

Slide 9: Dulles Greenway Financial performance
Dulles Greenway Financial performance Greenway’s revenue and EBITDA during 2018 were impacted by competing roads, weather For personal use only events and Federal Government shutdowns, partially offset by toll growth and cost management • 2.91% increase in tolls effective 10 April 2019 • From 1 Janu

Slide 10: Warnow Financial performance
Warnow Financial performance Warnow’s recent performance is being driven by surrounding road works/closures and toll For personal use only increases 5 year financial performance (€m) – 100% 2018 financial performance 10.5% average daily traffic (ADT) growth underpinned by 76.8% temporary construct

Slide 11: ALX distribution growth
ALX distribution growth For personal use only ALX’s distribution guidance of 30.0 cps in 2019 represents a 25% increase on 2018 distribution Continued growth in distributions since 2013 ALX distributions (cps) 24.0 cents per security (cps) distribution paid in 2018 up 20% on 2017 12.015.0 30.0 cps d

Slide 12: For personal use only
For personal use only atlasarteria.com Page 11
Source: ASX announcement, May 2, 2019
More decks from Atlas Arteria
H1 2026 Earnings Presentation41 slides · Aug 27, 2026
H1 2026 Earnings Presentation39 slides · Aug 27, 2026
FY2025 Earnings Presentation42 slides · Feb 26, 2026
FY2025 Earnings Presentation44 slides · Feb 26, 2026
H1 2025 Earnings Presentation52 slides · Aug 28, 2025
Non-Deal Roadshow (June 2025)28 slides · June 2025